22 min listen
Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction
Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction
ratings:
Length:
21 minutes
Released:
Oct 25, 2023
Format:
Podcast episode
Description
Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD. Related Content: Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive
Released:
Oct 25, 2023
Format:
Podcast episode
Titles in the series (100)
JAMA Cardiology Editors' Summary: 2016-2-24 Online First: Editors' Summary by Robert Bonow, MD, Editor in Chief of JAMA Cardiology, for February 24, 2016, with Deputy Editors Robert Harrington, MD, Marc Sabatine, MD, Clyde Yancy, MD, and Michael Pencina, PhD by JAMA Cardiology Author Interviews